Figure 5From: Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trialValue of further research on IVIG for severe sepsis (and septic shock): population partial EVPI (EVPPI) for groups of uncertain parameters, according to model for the synthesis of effectiveness evidence (see Table 2for detailed specification of the models). IVIG, intravenous immunoglobulin; EVPI, expected value of perfect information; EVPPI, partial EVPI.Back to article page